UAB Kirklin Clinic
Birmingham, Alabama, 35294, United States
NCT Number: NCT00903435
The purpose of this study is to determine whether more than one subpopulation exists of patients with the diagnosis of Interstitial Cystitis (IC) based on sensory testing and to determine if subjects with IC have normal counterirritation-related modulatory systems.
Looking for future studies?
Notify Me19 year–65 year
All sexes
Observational
Birmingham, Alabama, 35294, United States
To determine whether more than one subpopulation exists of patients with the diagnosis of Interstitial Cystitis (IC) based on sensory testing and to determine if subjects with IC have normal counterirritation-related modulatory systems. Previous studies by the PI suggest that two populations of subjects are present in the IC population but a larger number of subjects with IC would need to be tested in order to determine if this were indeed true. Other studies have demonstrated that counterirritation-related effects are absent in several chronic pain populations including fibromyalgia and chronic headaches. Identification of a subset of IC patients or the identification of a failure of counterirritation-related effects may predict responses to therapeutic interventions.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No therapeutic intervention will be given. Quantitative Sensory Testing, thermal/mechanical/ischemic stimulus will be performed.
Time frame: One and a half to two hours
Timothy Ness, MD
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01559961
Cystitis, Cystitis, Interstitial
Brampton, Ontario, Canada
View Trial DetailsNCT06719232
Bladder Cancer, Bladder Disease
Budapest, Hungary
View Trial DetailsNCT06232200
Bladder Pain Syndrome, Cystitis
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT03844412
Back Pain, Brain Diseases
Los Angeles, California, United States
View Trial Details